Vanguard Group Inc Syndax Pharmaceuticals Inc Transaction History

Vanguard Group Inc

$5.46 Trillion
Q3 2024

A detailed history of Vanguard Group Inc transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, Vanguard Group Inc holds 4,886,974 shares of SNDX stock, worth $78.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,886,974

Previous 4,797,089 1.87%

Holding current value

$78.7 Million

Previous $98.5 Million 4.48%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$17.93 - $24.81 $1.61 Million - $2.23 Million	89,885 Added 1.87%	4,886,974 $94.1 Million
Q2 2024 Aug 13, 2024	SELL	$18.82 - $23.79 $2.44 Million - $3.09 Million	-129,895 Reduced 2.64%	4,797,089 $98.5 Million
Q1 2024 May 10, 2024	BUY	$19.71 - $24.57 $11.7 Million - $14.5 Million	591,631 Added 13.65%	4,926,984 $117 Million
Q4 2023 Feb 14, 2024	BUY	$11.39 - $21.67 $8.18 Million - $15.6 Million	718,051 Added 19.85%	4,335,353 $93.7 Million
Q3 2023 Nov 14, 2023	BUY	$14.52 - $21.77 $502,856 - $753,938	34,632 Added 0.97%	3,617,302 $52.5 Million
Q2 2023 Aug 14, 2023	BUY	$19.35 - $22.31 $1.66 Million - $1.91 Million	85,585 Added 2.45%	3,582,670 $75 Million
Q1 2023 May 15, 2023	BUY	$20.66 - $28.98 $2.76 Million - $3.87 Million	133,635 Added 3.97%	3,497,085 $73.9 Million
Q4 2022 Feb 10, 2023	BUY	$20.64 - $26.24 $11.6 Million - $14.7 Million	561,151 Added 20.02%	3,363,450 $85.6 Million
Q3 2022 Nov 14, 2022	BUY	$18.51 - $24.79 $396,039 - $530,406	21,396 Added 0.77%	2,802,299 $67.3 Million
Q2 2022 Aug 12, 2022	BUY	$13.64 - $19.48 $4.75 Million - $6.79 Million	348,465 Added 14.33%	2,780,903 $53.5 Million
Q1 2022 May 13, 2022	BUY	$14.84 - $22.15 $1.41 Million - $2.11 Million	95,068 Added 4.07%	2,432,438 $42.3 Million
Q4 2021 Feb 14, 2022	BUY	$15.23 - $22.47 $2.56 Million - $3.77 Million	167,964 Added 7.74%	2,337,370 $51.2 Million
Q3 2021 Nov 12, 2021	BUY	$13.87 - $19.8 $841,326 - $1.2 Million	60,658 Added 2.88%	2,169,406 $41.5 Million
Q2 2021 Aug 13, 2021	BUY	$13.42 - $25.18 $28.3 Million - $53.1 Million	2,108,748 New	2,108,748 $36.2 Million

Others Institutions Holding SNDX

# of Institutions

227

Shares Held

88.3M

Call Options Held

1.01M

Put Options Held

692K

View Full List

About Syndax Pharmaceuticals Inc

Ticker SNDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,565,200
Market Cap $911M
Description
Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...

More about SNDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Syndax Pharmaceuticals Inc Transaction History